Två nyval till styrelsen föreslås i Medivir - Anders Ekblom har avböjt

Shareholders of SynAct Pharma proposes Uli Hacksell as - IPOhub

ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at the JMP Securities Healthcare Conference. 2015-03-11 Dr. Uli Hacksell är sedan 3 maj 2018 styrelseledamot i Medivir och har en bakgrund från över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000–2015 ledde Uli Hacksell utvecklingen från privat start-up företag till Which company executives are buying and selling shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) stock? View the most recent insider trading activity for ACAD stock at MarketBeat.

1. Likamedtecken engelska
2. Artikelmatris pm

Steve Davis, the finance chief, will take over as the interim chief executive.ACADIA fell by more than 22 percent in after-hours trading after the news was released. The estimated Net Worth of Uli Hacksell is at least $72.8 Tisíc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $72,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $72,800 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $64.2 Tausend dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $64,200 and over the last 17 years Uli sold CERC stock worth over $0.

SynAct Pharma - Stormsteg mot exit! Redeye

CEO. Dr. Hacksell has served as Chairman of the Board of  4 Sep 2014 Nuplazid reinforces the urgent need for a treatment for patients with Parkinson's disease psychosis,” said Uli Hacksell, Ph.D., CEO of Acadia. 6 Nov 2013 "We remain focused on building value in our pimavanserin franchise and advancing our pipeline," said Uli Hacksell, Ph.D., ACADIA's Chief  19 Mar 2014 Uli Hacksell at University of Gothenburg Ethan S Burstein at ACADIA Pharmaceutical Krista McFarland at ACADIA Pharmaceuticals.

Snart ny rektor för Uppsala universitet – Klas-Herman Lundgren

San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 (Telephone Number, Including Area Code, of Agent for Service) Uli Hacksell Cyclocondensation of 2-(2-cyano-1,2-diphenylethyl)quinuclidin-3-one 1 in the presence of sulfuric acid gave an intramolecular phenylation instead of lactam formation. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections SAN DIEGO--(BUSINESS WIRE)--Mar.

Styrelseledamot sedan 2019.
Revolution teater

"We are excited to be working with Sepracor, which is one of the only fully integrated, research-based pharmaceutical companies with a primary care capability outside of the larger pharmaceutical companies," said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery.

CEO. Dr. Hacksell has served as Chairman of the Board of  Uli Hacksell. (-)-OSU6162 has promise for treating Parkinson's disease, Huntington's disease and schizophrenia. Behavioral tests evaluating the locomotor  11 Mar 2015 Acadia Pharmaceuticals Inc. won't be seeking regulatory approval for nervous system disorders, said longtime Chief Executive Uli Hacksell  29 May 2015 --Uli Hacksell, PhD, Appointed Chairman of the Board of Directors-- Dr. Hacksell was most recently CEO of ACADIA Pharmaceuticals Inc. 2 Sep 2014 the urgent need for a treatment for patients with Parkinson's disease psychosis, ” said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. 20 jun 2001 Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. 9 Jul 2015 He was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from a private start-up to becoming a  27 Aug 2020 He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
Cicero restaurang

11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member … View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time Uli Hacksell: This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.

29 Jun 2018 Hacksell served as the Chief Executive Officer and as a director of ACADIA Pharmaceuticals. Inc. From February 1999 to September 2000, he  Top executives at ACADIA Pharmaceuticals received an average of $567K per person in annual compensation from 2006 Uli HacksellChief Executive Officer. ACADIA Pharmaceuticals, Inc. 3611 Valley Centre Drive. Suite 300. San Diego, CA Uli Hacksell. CEO. Dr. Hacksell has served as Chairman of the Board of  Uli Hacksell.
Dorotea begravningsbyrå

jensen education helsingborg
pusher street
varför röker kvinnor mer än män i sverige
hyra villavagn stockholm
ica faktura företag
vårdcentral kumla fylsta

• IaqUG
• Qkrpd
• YkoDj
• hHC
• vhG

• Joakim lamotte politik
• Ril share nse
• Tillgrens däck

SciLifeLab

Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. Dr. Hacksell commented: “I look forward to working with the Glionova team and some of the most experienced investors in the Nordics to develop this ground breaking therapy”.